U.S. General Surgery Devices Market Summary

The U.S. general surgery devices market size was estimated at USD 5.22 billion in 2023 and is projected to expand at a CAGR of 8.52% from 2024 to 2030. Several factors are contributing to this growth, including the rising geriatric population, increasing demand for plastic surgeries, and the growing prevalence of orthopedic disorders across different age groups. Additionally, the rising number of invasive surgeries for the treatment of various chronic illnesses such as cardiovascular diseases, diabetes, and cancer is one of the most significant drivers accelerating the market growth in the coming years.

The major driving factors influencing the expansion of this market are linked to modern lifestyle habits, including sedentary behavior, poor dietary patterns, and lack of adequate physical activity. These factors collectively contribute to the development of chronic health conditions such as cancer, diabetes, obesity, and cardiovascular disorders. According to statistics from the National Institute of Diabetes and Digestive and Kidney Diseases, 42.7% of the U.S. population is obese, while 30.7% is overweight. The rising prevalence of obesity has been a critical factor behind the increasing number of surgical interventions, particularly median sternotomy procedures, which are expected to significantly fuel segment growth.

Key Market Trends & Insights

• Based on type, disposable surgical supplies dominated the market with a share of 52% in 2023. This dominance is primarily attributed to the growing incidence of chronic diseases including cancer, cardiovascular disorders, and orthopedic conditions, which increase the overall need for surgical treatments. Moreover, the growing demand for plastic surgeries, fueled by rising aesthetic awareness and improved surgical outcomes, has further strengthened the preference for disposable supplies, ensuring safety and efficiency during procedures.
• Based on application, orthopedic surgery accounted for the largest market share in 2023. This growth can be credited to the availability of a large number of orthopedic surgeons in the U.S. along with the rising adoption of technologically advanced orthopedic procedures designed to improve patient outcomes. The increasing burden of musculoskeletal conditions, particularly osteoarthritis and joint-related ailments, has further supported the dominance of this application segment.
• Based on end-use, hospitals captured the largest market share of 59% in 2023. This dominance stems from the high volume of surgeries performed in hospitals, supported by their infrastructure, access to advanced surgical devices, and the presence of skilled healthcare professionals. According to the American Hospital Association (AHA) Hospital Statistics, approximately 33.68 million hospital admissions were reported in 2024, highlighting the central role of hospitals in performing surgical procedures and driving demand for general surgery devices.

Order a free sample PDF of the U.S. General Surgery Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 5.22 billion
• 2030 Projected Market Size: USD 9.24 billion
• CAGR (2024 - 2030): 8.52%

Key Companies & Market Share Insights

Major companie soperating in the U.S General surgery devices market include Johnson & Johnson Service, Inc., Conmed Corporation, Stryker,Integra LifeSciences, and Becton, Dickinson, and Company (BD) among others.

These companies prioritize advancing existing technologies to improve patient outcomes and enhance surgical efficiency. Additionally, companies engage in mergers and acquisitions, innovative product launches, and regional expansion efforts to drive market growth.

Key Players

• Johnson & Johnson Service, Inc.
• Conmed Corporation
• Integra LifeSciences
• Becton, Dickinson, and Company (Bd)
• Cadence Inc
• Integer Holdings Corporation
• Stryker
• Boston Scientific Corporation
• 3M Healthcare
• Biomez, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. general surgery devices market is poised for significant growth, driven by the aging population, rising prevalence of chronic diseases, and the increasing demand for both invasive and plastic surgeries. The dominance of disposable surgical supplies highlights the growing preference for safety and efficiency in surgical practices. Orthopedic surgeries remain a critical application area, supported by advanced techniques and a large patient base with musculoskeletal disorders. Hospitals continue to lead as the primary end-use segment due to high admission rates and surgical volume. With advancing technology and evolving healthcare needs, the market is expected to expand steadily in the years ahead.